Covered recipient · General Payments record
SARITHA TIRUMALASETTY
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2022–2024
$749.86
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $187.65 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $57.79 | 2 |
| PFIZER INC. | $38.55 | 2 |
| Corcept Therapeutics | $32.96 | 2 |
| Novo Nordisk AS | $32.84 | 2 |
| Xeris Pharmaceuticals, Inc. | $25.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $29.10 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116179166 | CMS |
| Amgen Inc. | $28.69 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116179170 | CMS |
| Corcept Therapeutics | $16.51 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117767001 | CMS |
| Corcept Therapeutics | $16.45 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117767025 | CMS |
| Novo Nordisk Inc | $14.10 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096792683 | CMS |
| Novo Nordisk Inc | $18.74 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097340270 | CMS |
| PFIZER INC. | $19.00 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131377239 | CMS |
| PFIZER INC. | $19.55 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131927868 | CMS |
| Xeris Pharmaceuticals, Inc. | $25.51 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144612714 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.